← All indications
Cholera
An acute diarrheal disease endemic in India and Southeast Asia whose causative agent is VIBRIO CHOLERAE. This condition can lead to severe dehydration in a matter of hours unless quickly treated.
Drugs by status
Approved for this indication (5)
Phase 4 trials (1)
Phase 3 trials (5)
Phase 2 trials (13)
Other trials (3)
Organizations
Organization Involved with Phase 4 Indications (12)
- Sanofi
- Sanofi-Aventis
- PaxVax, Inc.
- Shantha Biotechnics Limited
- Armauer Hansen Research Institute, Ethiopia
- Indian Council of Medical Research
- International Vaccine Institute
- Johns Hopkins University
- University of Maryland
- National Institute of Cholera and Enteric Diseases, Kolkata, India
- Government of Ethiopia
- Christian Medical College, Vellore, India
Organization Involved with Phase 3 Indications (10)
Organization Involved with Phase 2 Indications (13)
- Avant Immunotherapeutics
- National Institutes of Health (NIH)
- Harvard University
- Emory University
- Siriraj Hospital
- University of Gothenburg
- Bill and Melinda Gates Foundation
- Centre pour le developpement des vaccines, Mali
- Government of Vietnam
- Vaccine Technologies Inc.
- Pharmaron
- PATH
- Meilleur Accès aux Soins de Santé (M.A. Santé)
Organization Involved with Phase 1 Indications (4)
Organization Involved with Other Experimental Indications (9)